arrow
F

Françis Guillemin

institut national de la santé et de la recherche médicale (inserm)
H指数:84
被引数:7.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deterministic Economic Modelling Study of Tafamidis in Transthyretin Amyloid Cardiomyopathy Across Four European Healthcare Systems

在四种欧洲医疗保健系统中的转甲状腺素蛋白淀粉样变性心肌病中,对Tafamidis的确定性经济模型研究

2026-08-180
PRE
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains

2023年ACR/EULAR抗磷脂综合征分类标准制定,第III-A/B阶段报告:定义和构建临床及实验室领域

2025-11-260
PRE
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis

螺内酯在高危心血管不良事件风险的慢性血液透析患者中的疗效(ALCHEMIST):一项多中心、双盲、随机、安慰剂对照试验及更新Meta分析

2025-08-140
PRE
Risk factors for the development of knee osteoarthritis across the lifespan: A systematic review and meta-analysis

膝关节骨关节炎发展的全生命周期风险因素:一项系统评价和Meta分析

2025-03-310
OAAI
Modified Rankin Scale at 90 Days Versus National Institutes of Health Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials

90天时改良Rankin量表与24小时时美国国立卫生研究院卒中量表作为急性卒中试验的主要结局

2025-02-190
OAAI
Modified Rankin Score at 90 Days vs. NIH Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials

90天改良Rankin评分与24小时NIH卒中量表作为急性卒中试验的主要结局指标

STROKE
IF8.9
2025-02-010
PRE
Collating the voice of people with autoimmune diseases: Methodology for the third phase of the COVAD studies (vol 44, pg 1233, 2024)
2024-10-140
OAAI
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis
2024-09-301
OA
HERMES-24 Score Derivation and Validation for Simple and Robust Outcome Prediction After Large Vessel Occlusion Treatment

大血管闭塞治疗后简单而稳健的结果预测的HERMES-24评分推导和验证

STROKE
IF8.9
2024-08-010
PRE
Role of dietary intake and physical activity in reducing weight social inequalities among adolescents: an application of G-formula to PRALIMAP-INÈS trial

饮食摄入和体育锻炼在减轻体重中的作用青少年中的社会不平等: G配方在pralimap-inès试验中的应用

2024-05-271
OA